Figures & data
Figure 1 Meta-analysis of randomized trials of hMG versus rFSH following a long down-regulation protocol for the outcome of live births. Adapted with permission from Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IV F or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23(2):310–315.Citation78 Copyright © 2008 Oxford University Press.
![Figure 1 Meta-analysis of randomized trials of hMG versus rFSH following a long down-regulation protocol for the outcome of live births. Adapted with permission from Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IV F or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23(2):310–315.Citation78 Copyright © 2008 Oxford University Press.](/cms/asset/81340f6d-d6bf-4c84-b4dc-b856ebef0995/dbtt_a_12160339_f0001_c.jpg)
Table 1 Classification of disorders of ovulation
Figure 2 Meta-analysis of randomized trials of hMG versus rFSH for the outcome of pregnancy rate per patient in women undergoing ovulation induction for subfertility associated with polycystic ovarian syndrome. Bayram N, van Wely M, van Der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2001;2(2):CD002121.Citation128 Copyright © Cochrane Collaboration, reproduced with permission.
![Figure 2 Meta-analysis of randomized trials of hMG versus rFSH for the outcome of pregnancy rate per patient in women undergoing ovulation induction for subfertility associated with polycystic ovarian syndrome. Bayram N, van Wely M, van Der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev. 2001;2(2):CD002121.Citation128 Copyright © Cochrane Collaboration, reproduced with permission.](/cms/asset/faedc55c-06f0-4474-ba9f-2e60c58a85ea/dbtt_a_12160339_f0002_c.jpg)